Back
Summit Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
58
SMMT
Summit Therapeutics
Last Price:
$25.03
Seasonality Move:
17.66%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.23 | Buy |
| 20-day SMA: | 21.52 | Buy |
| 50-day SMA: | 22.78 | Buy |
| 200-day SMA: | 20.98 | Buy |
| 8-day EMA: | 13.12 | Buy |
| 20-day EMA: | 6.39 | Buy |
| 50-day EMA: | 2.78 | Buy |
| 200-day EMA: | 0.73 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.66 | Buy |
| Relative Strength Index (14 RSI): | 63.97 | Buy |
| Chaikin Money Flow: | 1243142 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.69 - 23.03) | Buy |
| Bollinger Bands (100): | (18.75 - 25.21) | Buy |
Summit Therapeutics Technical Analysis
| Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 25.88 while SMMT 8-day simple moving average is 23.23, which is a Buy signal.
-
The stock price of SMMT is 25.88 while Summit Therapeutics 20-day SMA is 21.52, which makes it a Buy.
-
Summit Therapeutics 50-day simple moving average is 22.78 while SMMT share price is 25.88, making it a Buy technically.
-
SMMT stock price is 25.88 and Summit Therapeutics 200-day simple moving average is 20.98, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
58
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a BuyThe current Summit Therapeutics [SMMT] share price is $25.88. The Score for SMMT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
19.2B
Price in USD:
25.88
Share Volume:
2.2M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
8.24
Buy
58
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 25.88 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 25.88 while SMMT 8-day exponential moving average is 13.12, which is a Buy signal.
-
The stock price of SMMT is 25.88 while Summit Therapeutics 20-day EMA is 6.39, which makes it a Buy.
-
Summit Therapeutics 50-day exponential moving average is 2.78 while SMMT share price is 25.88, making it a Buy technically.
-
SMMT stock price is 25.88 and Summit Therapeutics 200-day simple moving average is 0.73, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 4.66, suggesting Summit Therapeutics is a Buy
-
Summit Therapeutics Relative Strength Index (RSI) is 63.97, which suggest Summit Therapeutics is overbought
-
The Bollinger Bands (25) for Summit Therapeutics is (19.69 - 23.03), which suggest Summit Therapeutics is a Buy
-
The Bollinger Bands (100) for Summit Therapeutics is (18.75 - 25.21), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.